Medicine for treating lung diseases

A technology for pulmonary diseases and drugs, applied in the field of drugs for the treatment of pulmonary diseases, can solve the problems of single therapeutic effect, inability to treat pulmonary diseases effectively at the same time, toxic and side effects, etc. good effect

Inactive Publication Date: 2021-07-20
周永杰
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some traditional Chinese medicines will also produce certain toxic and side effects while treating diseases, and the therapeutic efficacy is single, so they cannot effectively treat common lung diseases such as pulmonary nodules, bullae, pleural effusion, and pulmonary effusion at the same time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Take 3 parts of Bletilla striata, 3 parts of Baibu, 3 parts of Radix Ginseng, 3 parts of Codonopsis pilosula, 3 parts of donkey-hide gelatin, 3 parts of Asparagus, 3 parts of Pingbei, 3 parts of Astragalus, 3 parts of Trichosanthes, 3 parts of Prunella vulgaris, and 1 part of Chonglou , 1 part of Banzhilian, 1 part of Snake Grass, 1 part of Licorice, 1 part of Angelica, 3 parts of Anemarrhena, 3 parts of Lily, 3 parts of Habitat, 3 parts of Houttuynia cordata, 2 parts of Gecko, 3 parts of Campanulaceae, Ophiopogon japonicus 3 parts are crushed into powder and passed through a 100-mesh sieve, and the sifted medicinal powders are mixed;

[0013] The mixed powder is taken orally directly or made into pills or tablets by machine;

Embodiment 2

[0015] Take 10 parts of Baiji, 20 parts of Baibu, 10 parts of Radix Ginseng, 10 parts of Dangshen, 10 parts of Ejiao, 10 parts of Asparagus, 20 parts of Pingbei, 10 parts of Astragalus, 10 parts of Trichosanthes, 20 parts of Prunella vulgaris, and 10 parts of Chonglou , 20 parts of barbata, 20 parts of white snake grass, 10 parts of licorice, 10 parts of angelica, 20 parts of Anemarrhena, 20 parts of lily, 10 parts of habitat, 20 parts of Houttuynia cordata, 5 parts of gecko, 10 parts of platycodon grandiflorum, Ophiopogon japonicus After 15 parts are crushed into powder, pass through a 100-mesh sieve, and the powders of the medicinal materials after the sieve are mixed;

[0016] The mixed powder is taken orally directly or made into pills or tablets by machine;

Embodiment 3

[0018] Take 20 parts of Baiji, 30 parts of Baibu, 15 parts of Radix Ginseng, 15 parts of Codonopsis, 20 parts of Ejiao, 20 parts of Asparagus, 30 parts of Pingbei, 20 parts of Astragalus, 20 parts of Trichosanthes, 30 parts of Prunella vulgaris, and 15 parts of Chonglou , 30 parts of barbata, 30 parts of white snake grass, 15 parts of licorice, 20 parts of angelica, 30 parts of anemarrhena, 30 parts of lily, 20 parts of habitat, 30 parts of Houttuynia cordata, 10 parts of gecko, 20 parts of platycodon, radix japonicus After 30 parts are crushed into powder, pass through a 100-mesh sieve, and the powders of the medicinal materials after the sieve are mixed;

[0019] The mixed powder is taken orally directly or made into pills or tablets by machine;

[0020] Treatment case:

[0021] 1, Wang, female 53 years old, went to the hospital for examination and was diagnosed as pulmonary nodules and bullae, and recovered within 4 months after taking the medicine of the present invention...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating lung diseases. The medicine comprises the following raw materials in parts by weight: 3-20 parts of bletilla striata, 3-30 parts of radix stemonae, 3-15 parts of adenophora stricta, 3-15 parts of codonopsis pilosula, 3-20 parts of colla corii asini, 3-20 parts of radix asparagi, 3-30 parts of bulbus fritillariae ussuriensis, 3-20 parts of astragalus membranaceus, 3-20 parts of radices trichosanthis, 3-30 parts of selfheal, 1-15 parts of paris polyphylla, 1-30 parts of sculellaria barbata, 1-30 parts of hedyotis diffusa, 1-15 parts of liquorice, 1-20 parts of angelica sinensis, 3-30 parts of rhizoma anemarrhenae, 3-30 parts of lily, 3-20 parts of radix rehmanniae, 3-30 parts of herba houttuyniae, 2-10 parts of tokay gecko, 3-20 parts of platycodon grandiflorum and 3-30 parts of radix ophiopogonis. The medicine has the beneficial effects that according to a traditional Chinese medicine compatibility principle, the medicine can be used for effectively treating diseases such as pulmonary tuberculosis, pulmonary bulla, pulmonary nodule, hydropleural effusion, hydropneumosis and cough, and is good in treatment effect, low in treatment cost and free of toxic and side effects.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating lung diseases. Background technique [0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis infection, which is mainly transmitted through the respiratory tract. It is one of the diseases with the longest history and serious consequences that endanger human life and health. With the application of antibiotics, drug-resistant tuberculosis has gradually become a difficult problem in the prevention and control of tuberculosis. At present, the situation of tuberculosis prevention and control is still very grim. The use of western medicine chemotherapy technology can improve the cure rate of tuberculosis and reduce the mortality rate. For active and drug-sensitive tuberculosis, the "supervised short-course chemotherapy" strategy is generally adopted, that is, four antibiotics (isoniazid, rifampicin, eth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/904A61P7/10A61P11/00A61P11/14A61P31/06A61K35/36A61K35/583
CPCA61K35/36A61K35/583A61K36/23A61K36/232A61K36/34A61K36/342A61K36/344A61K36/346A61K36/428A61K36/481A61K36/484A61K36/536A61K36/539A61K36/748A61K36/78A61K36/804A61K36/896A61K36/8964A61K36/8965A61K36/8966A61K36/8967A61K36/8968A61K36/898A61K36/904A61P7/10A61P11/00A61P11/14A61P31/06A61K2300/00
Inventor 周永杰周春宇
Owner 周永杰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap